Management of Femoral Large-Bore Access and Closure During Microaxial Flow Pump-Supported Interventions - Summary - MDSpire

Management of Femoral Large-Bore Access and Closure During Microaxial Flow Pump-Supported Interventions

  • By

  • Vergallo, Rocco

  • Lombardi, Marco

  • Macchione, Andrea

  • Pescetelli, Fabio

  • Benenati, Stefano

  • Vercellino, Matteo

  • Secco, Gioel Gabrio

  • Gonzalo, Nieves

  • Escaned, Javier

  • Porto, Italo

  • April 29, 2026

  • 0 min

Share

Objective:

To provide a comprehensive review of strategies for managing femoral access and closure in patients undergoing microaxial flow pump-assisted procedures.

Key Findings:
  • Large-bore arterial access increases the risk of vascular complications.
  • Improved imaging techniques enhance the safety of femoral access.
  • Pre-closure methods are effective in HR-PCI but often not feasible in CS cases.
Interpretation:

Effective management of femoral access and closure is critical to reducing morbidity and mortality associated with large-bore arterial access in mAFP procedures.

Limitations:
  • The review may not cover all potential complications associated with large-bore access.
  • Specific outcomes related to different closure techniques were not detailed.
Conclusion:

A modern approach to femoral access and closure is essential for improving patient outcomes in mAFP-assisted procedures.

Original Source(s)

Management of Femoral Large-Bore Access and Closure During Microaxial Flow Pump-Supported Interventions

  • by Vergallo, Rocco , Lombardi, Marco , Macchione, Andrea , Pescetelli, Fabio , Benenati, Stefano , Vercellino, Matteo , Secco, Gioel Gabrio, Gonzalo, Nieves , Escaned, Javier , Porto, Italo

  • April 29, 2026

Related Content

Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes

Complete revascularization and heart failure risk in acute coronary syndrome across the ejection fraction spectrum: focus on LVEF-dependent effects

Side Effects: Variety Is Overrated

The organ you forgot, the cells that age unevenly, the AI that admits ignorance, and the diet advice that sounds wrong but isn't: medicine's next moves are hiding in plain sight.